SUTENT
Identification of Sutent
Please sign up for a free trial to see the description of this product.
Examples of the descriptions of OTHER drugs:
Lipitor 10 mg
Apo-Irbesartan 150 mg
Crestor 20 mg
Google image searchProduct monograph
Active ingredient
sunitinib (sunitinib malate), 25 MG
DIN: 02280809
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: PFIZER CANADA ULC
Date: 22-JUN-2006
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
- L01EX — Other protein kinase inhibitors (ATC, ATC/DDD)
- L01EX01 — SUNITINIB (ATC/DDD)
Reference brand drug: Sutent
